| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |